Literature DB >> 11337362

Expression profiling of renal epithelial neoplasms: a method for tumor classification and discovery of diagnostic molecular markers.

A N Young1, M B Amin, C S Moreno, S D Lim, C Cohen, J A Petros, F F Marshall, A S Neish.   

Abstract

The expression patterns of 7075 genes were analyzed in four conventional (clear cell) renal cell carcinomas (RCC), one chromophobe RCC, and two oncocytomas using cDNA microarrays. Expression profiles were compared among tumors using various clustering algorithms, thereby separating the tumors into two categories consistent with corresponding histopathological diagnoses. Specifically, conventional RCCs were distinguished from chromophobe RCC/oncocytomas based on large-scale gene expression patterns. Chromophobe RCC/oncocytomas displayed similar expression profiles, including genes involved with oxidative phosphorylation and genes expressed normally by distal nephron, consistent with the mitochondrion-rich morphology of these tumors and the theory that both lesions are related histogenetically to distal nephron epithelium. Conventional RCCs underexpressed mitochondrial and distal nephron genes, and were further distinguished from chromophobe RCC/oncocytomas by overexpression of vimentin and class II major histocompatibility complex-related molecules. Novel, tumor-specific expression of four genes-vimentin, class II major histocompatibility complex-associated invariant chain (CD74), parvalbumin, and galectin-3-was confirmed in an independent tumor series by immunohistochemistry. Vimentin was a sensitive, specific marker for conventional RCCs, and parvalbumin was detected primarily in chromophobe RCC/oncocytomas. In conclusion, histopathological subtypes of renal epithelial neoplasia were characterized by distinct patterns of gene expression. Expression patterns were useful for identifying novel molecular markers with potential diagnostic utility.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11337362      PMCID: PMC1891957          DOI: 10.1016/S0002-9440(10)64120-X

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  54 in total

Review 1.  Exploring expression data: identification and analysis of coexpressed genes.

Authors:  L J Heyer; S Kruglyak; S Yooseph
Journal:  Genome Res       Date:  1999-11       Impact factor: 9.043

2.  Specific genetic changes of diagnostic importance in chromophobe renal cell carcinomas.

Authors:  P Bugert; C Gaul; K Weber; J Herbers; M Akhtar; B Ljungberg; G Kovacs
Journal:  Lab Invest       Date:  1997-02       Impact factor: 5.662

3.  Discovery and analysis of inflammatory disease-related genes using cDNA microarrays.

Authors:  R A Heller; M Schena; A Chai; D Shalon; T Bedilion; J Gilmore; D E Woolley; R W Davis
Journal:  Proc Natl Acad Sci U S A       Date:  1997-03-18       Impact factor: 11.205

Review 4.  Involvement of multiple loci on chromosome 3 in renal cell cancer development.

Authors:  A van den Berg; C H Buys
Journal:  Genes Chromosomes Cancer       Date:  1997-06       Impact factor: 5.006

5.  Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling.

Authors:  A A Alizadeh; M B Eisen; R E Davis; C Ma; I S Lossos; A Rosenwald; J C Boldrick; H Sabet; T Tran; X Yu; J I Powell; L Yang; G E Marti; T Moore; J Hudson; L Lu; D B Lewis; R Tibshirani; G Sherlock; W C Chan; T C Greiner; D D Weisenburger; J O Armitage; R Warnke; R Levy; W Wilson; M R Grever; J C Byrd; D Botstein; P O Brown; L M Staudt
Journal:  Nature       Date:  2000-02-03       Impact factor: 49.962

6.  Renal oncocytoma: a reappraisal of morphologic features with clinicopathologic findings in 80 cases.

Authors:  M B Amin; T B Crotty; S K Tickoo; G M Farrow
Journal:  Am J Surg Pathol       Date:  1997-01       Impact factor: 6.394

Review 7.  Cytokine combinations: therapeutic use in patients with advanced renal cell carcinoma.

Authors:  R M Bukowski
Journal:  Semin Oncol       Date:  2000-04       Impact factor: 4.929

8.  Fluorescence in situ hybridization analysis of renal oncocytoma reveals frequent loss of chromosomes Y and 1.

Authors:  J A Brown; S Takahashi; A Alcaraz; T J Borell; K L Anderl; J Qian; D L Persons; D G Bostwick; M M Lieber; R B Jenkins
Journal:  J Urol       Date:  1996-07       Impact factor: 7.450

Review 9.  Aggressive variants of chromophobe renal cell carcinoma.

Authors:  A A Renshaw; E P Henske; K R Loughlin; C Shapiro; D S Weinberg
Journal:  Cancer       Date:  1996-10-15       Impact factor: 6.860

10.  MHC class II antigen-associated invariant chain on renal cell cancer may contribute to the anti-tumor immune response of the host.

Authors:  T Saito; M Kimura; T Kawasaki; S Sato; Y Tomita
Journal:  Cancer Lett       Date:  1997-05-01       Impact factor: 8.679

View more
  79 in total

1.  Typical signs of oncocytic papillary renal cell carcinoma in everyday clinical praxis.

Authors:  T Urge; O Hes; J Ferda; Z Chudácek; V Eret; M Michal; M Brunelli; G Martignoni; M Hora
Journal:  World J Urol       Date:  2010-05-08       Impact factor: 4.226

2.  Validation of cDNA microarray gene expression data obtained from linearly amplified RNA.

Authors:  S D Jenson; R S Robetorye; S D Bohling; J A Schumacher; J W Morgan; M S Lim; K S J Elenitoba-Johnson
Journal:  Mol Pathol       Date:  2003-12

Review 3.  Expression of galectins in cancer: a critical review.

Authors:  Frédéric van den Brûle; Stèphane Califice; Vincent Castronovo
Journal:  Glycoconj J       Date:  2002       Impact factor: 2.916

4.  Towards functional glycomics by localization of binding sites for tissue lectins: lectin histochemical reactivity for galectins during diethylstilbestrol-induced kidney tumorigenesis in male Syrian hamster.

Authors:  Sven Saussez; Francois Lorfevre; Denis Nonclercq; Guy Laurent; Sabine André; Fabrice Journé; Robert Kiss; Gérard Toubeau; Hans-Joachim Gabius
Journal:  Histochem Cell Biol       Date:  2006-01-25       Impact factor: 4.304

Review 5.  Human copper-dependent amine oxidases.

Authors:  Joel Finney; Hee-Jung Moon; Trey Ronnebaum; Mason Lantz; Minae Mure
Journal:  Arch Biochem Biophys       Date:  2014-01-06       Impact factor: 4.013

6.  Microarray analysis of B-cell lymphoma cell lines with the t(14;18).

Authors:  Ryan S Robetorye; Sandra D Bohling; John W Morgan; G Chris Fillmore; Megan S Lim; Kojo S J Elenitoba-Johnson
Journal:  J Mol Diagn       Date:  2002-08       Impact factor: 5.568

7.  Combined analysis of transcriptome and proteome data as a tool for the identification of candidate biomarkers in renal cell carcinoma.

Authors:  Barbara Seliger; Sven P Dressler; Ena Wang; Roland Kellner; Christian V Recktenwald; Friedrich Lottspeich; Francesco M Marincola; Maja Baumgärtner; Derek Atkins; Rudolf Lichtenfels
Journal:  Proteomics       Date:  2009-03       Impact factor: 3.984

8.  The proliferation marker thymidine kinase 1 level is high in normal kidney tubule cells compared to other normal and malignant renal cells.

Authors:  Pengcheng Luo; Naining Wang; Ellen He; Staffan Eriksson; Ji Zhou; Guozhu Hu; Jie Zhang; Sven Skog
Journal:  Pathol Oncol Res       Date:  2009-12-03       Impact factor: 3.201

9.  Microarray gene expression profiling using core biopsies of renal neoplasia.

Authors:  Craig G Rogers; Jonathon A Ditlev; Min-Han Tan; Jun Sugimura; Chao-Nan Qian; Jeff Cooper; Brian Lane; Michael A Jewett; Richard J Kahnoski; Eric J Kort; Bin T Teh
Journal:  Am J Transl Res       Date:  2009-01-01       Impact factor: 4.060

10.  Effect of invariant chain on major histocompatibility complex class I molecule expression and stability on human breast tumor cell lines.

Authors:  Xuede Lin; Xiaojian Wang; Haley L Capek; Laura C Simone; Amit Tuli; Chantey R Morris; Adrian J Reber; Joyce C Solheim
Journal:  Cancer Immunol Immunother       Date:  2008-10-01       Impact factor: 6.968

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.